Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (61-70 of 681) with videos related to

Pageof 69
Sort By:
Anaesthesia, Critical Care & Pain Medicine|July 20, 2019
Antimicrobial therapy during ECMO - customised dosing with therapeutic drug monitoring: The way to go?Mohd H Abdul-Aziz, Kiran Shekar, Jason A Roberts
Current Opinion in Infectious Diseases|October 3, 2020
Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence baseMohd H Abdul-Aziz, Federica Portunato, Jason A Roberts
Current Opinion in Pharmacology|June 30, 2015
Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimizationFekade Bruck Sime, Andrew A Udy, Jason A Roberts
American Journal of Respiratory and Critical Care Medicine|December 6, 2022
Reply to Fillatre <i>et al.</i> and Li <i>et al.</i>Mohd H Abdul-Aziz, Kiran Shekar, Jason A Roberts
Infectious Disease Reports|May 2, 2017
The Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the EvidenceSonali Coulter, Jason A Roberts, Krispin Hajkowicz, et al.
International Journal of Antimicrobial Agents|December 13, 2006
Cefepime versus ceftazidime: considerations for empirical use in critically ill patientsJason A Roberts, Steven A R Webb, Jeffrey Lipman
Current Opinion in Infectious Diseases|December 29, 2016
Antibiotic dosing for multidrug-resistant pathogen pneumoniaMohd H Abdul-Aziz, Jeffrey Lipman, Jason A Roberts
The Journal of Antimicrobial Chemotherapy|January 31, 2023
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae-authors' responseChandra Datta Sumi, Jason A Roberts, Fekade B Sime
JAMA|December 26, 2024
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics-ReplyJason A Roberts, Anthony Devaux, Mohd H Abdul-Aziz
Critical Care (London, England)|July 15, 2023
Comment: Is off-label medication use in the ICU a problem?Menino O Cotta, Jason A Roberts, Michael C Reade
Pageof 69

Showing results (61-70 of 681) with videos related to

Sort By:
Pageof 69
Anaesthesia, Critical Care & Pain Medicine|July 20, 2019
Antimicrobial therapy during ECMO - customised dosing with therapeutic drug monitoring: The way to go?Mohd H Abdul-Aziz, Kiran Shekar, Jason A Roberts
Current Opinion in Infectious Diseases|October 3, 2020
Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence baseMohd H Abdul-Aziz, Federica Portunato, Jason A Roberts
Current Opinion in Pharmacology|June 30, 2015
Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimizationFekade Bruck Sime, Andrew A Udy, Jason A Roberts
American Journal of Respiratory and Critical Care Medicine|December 6, 2022
Reply to Fillatre <i>et al.</i> and Li <i>et al.</i>Mohd H Abdul-Aziz, Kiran Shekar, Jason A Roberts
Infectious Disease Reports|May 2, 2017
The Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the EvidenceSonali Coulter, Jason A Roberts, Krispin Hajkowicz, et al.
International Journal of Antimicrobial Agents|December 13, 2006
Cefepime versus ceftazidime: considerations for empirical use in critically ill patientsJason A Roberts, Steven A R Webb, Jeffrey Lipman
Current Opinion in Infectious Diseases|December 29, 2016
Antibiotic dosing for multidrug-resistant pathogen pneumoniaMohd H Abdul-Aziz, Jeffrey Lipman, Jason A Roberts
The Journal of Antimicrobial Chemotherapy|January 31, 2023
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae-authors' responseChandra Datta Sumi, Jason A Roberts, Fekade B Sime
JAMA|December 26, 2024
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics-ReplyJason A Roberts, Anthony Devaux, Mohd H Abdul-Aziz
Critical Care (London, England)|July 15, 2023
Comment: Is off-label medication use in the ICU a problem?Menino O Cotta, Jason A Roberts, Michael C Reade
Pageof 69